PMID: 9543275May 16, 1998Paper

Effect of salmeterol on Haemophilus influenzae infection of respiratory mucosa in vitro

The European Respiratory Journal
R B DowlingR Wilson

Abstract

Haemophilus influenzae is a common bacterial pathogen causing human respiratory tract infections. We have previously shown that the beta2-agonist salmeterol reduces damage to the respiratory mucosa caused by Pseudomonas aeruginosa in vitro. We have now investigated the effect of salmeterol on H. influenzae infection of adenoid tissue in an organ culture by scanning electron microscopy. Tissue was preincubated with or without salmeterol (4x10(-7)M), prior to infection with H. influenzae and incubated for 12 or 24 h. Infected organ cultures had increased epithelial damage and decreased numbers of both ciliated and unciliated cells at 12h, which were significantly different (p < or = 0.01) from the controls at 24 h. Salmeterol (4x10(-7)M) significantly (p < or = 0.03) reduced damage and loss of ciliated cells in infected organ cultures at both 12 and 24, and significantly (p < or = 0.03) reduced loss of unciliated cells at 24 h. Salmeterol had no effect on the density of bacteria adhering to each individual mucosal feature or the total number of bacteria adhering to the organ culture. These results suggest that salmeterol protects the respiratory epithelium against Haemophilus influenzae-induced damage. The mechanism of salmeterol...Continue Reading

Citations

Sep 3, 2002·Pediatric Pulmonology·Nancy L HordvikJohn L Colombo
Dec 21, 2002·Pharmacology & Therapeutics·Peter J Barnes
Jul 27, 2000·The New England Journal of Medicine·P J Barnes
Jan 15, 2011·Clinical Microbiology Reviews·Marjolaine VareilleNicolas Regamey
Mar 11, 2000·American Journal of Respiratory and Critical Care Medicine·G P Anderson
Oct 7, 2003·American Journal of Respiratory Cell and Molecular Biology·Christelle CorauxEdith Puchelle
Feb 21, 2004·Critical Care : the Official Journal of the Critical Care Forum·Gavin D PerkinsFang Gao
Aug 27, 2003·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Kojiro Oguri
Nov 23, 2001·Pharmacotherapy·J D Adkison, S L Konzem
Feb 13, 2003·Drugs & Aging·Abebaw M Yohannes, Christopher C Hardy
Jun 9, 2004·Treatments in Respiratory Medicine·David A Lipson
Jan 8, 2014·American Journal of Respiratory and Critical Care Medicine·Gavin D PerkinsUNKNOWN BALTI-Prevention Collaborators
May 25, 2005·Fundamental & Clinical Pharmacology·Danuta J Herzyk
Apr 12, 2007·Expert Opinion on Pharmacotherapy·Sabina A AntoniuClaudio F Donner
Mar 16, 2001·Expert Opinion on Pharmacotherapy·S V Culpitt, D F Rogers
Jul 22, 2004·Expert Opinion on Pharmacotherapy·Mark T Dransfield, William C Bailey
Jul 30, 2014·Frontiers in Immunology·Jennifer M FeltonIan Dransfield
Dec 21, 2004·Pulmonary Pharmacology & Therapeutics·Duncan F Rogers
Aug 19, 2003·The Annals of Pharmacotherapy·John A DoughertyLoutfi S Aboussouan
Nov 18, 2005·Pulmonary Pharmacology & Therapeutics·Michael R EdwardsSebastian L Johnston
Feb 7, 2002·Hospital Medicine·Carol Llewellyn-Jones
Feb 13, 2016·The Cochrane Database of Systematic Reviews·Clare HalfhideJon Couriel
Jan 15, 2004·American Journal of Respiratory Medicine : Drugs, Devices, and Other Interventions·Susan M Cheer, Lesley J Scott
Feb 5, 2019·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·Shoroq M AltawalbehIman A Basheti
Jan 15, 2004·American Journal of Respiratory Medicine : Drugs, Devices, and Other Interventions·Hanneke J van der Woude, René Aalbers
Dec 5, 2002·The Journal of Allergy and Clinical Immunology·Matthias Salathe
Apr 16, 2003·Respiratory Medicine·A M MiddletonR Wilson
Jan 14, 2004·Chest·Donald P Tashkin, Christopher B Cooper

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.